University of Maryland Cancer Center — Baltimore, Maryland

University of Maryland Cancer Center is a clinical research site located in Baltimore, Maryland, United States.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Maryland Cancer Center has participated in 8 clinical trials with 1 currently active.

Therapeutic areas: Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma, Prostatic Neoplasms, Breast Cancer.

Sponsors: Biogen, Chronix Biomedical Corporation, Poseida Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Maryland Cancer Center?

University of Maryland Cancer Center has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Maryland Cancer Center conducted?

University of Maryland Cancer Center has 8 clinical trials on record, with 1 currently active. Their work covers Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma, Prostatic Neoplasms, Breast Cancer.

Is University of Maryland Cancer Center accredited by Crixeo Health?

Yes — University of Maryland Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Maryland Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.